Gavin Scott

Gavin Scott is a fundamental senior research analyst at Causeway Capital Management LLC, based in Los Angeles. He specializes in covering the pharmaceuticals and biotechnology sectors, focusing on in-depth fundamental research of healthcare companies and industry trends. His analyses include evaluating regulatory developments such as the Inflation Reduction Act and global market dynamics impacting pharmaceutical valuations and innovation.

Prior to joining Causeway in August 2022, Mr. Scott was vice president of Equity Research - Large Cap Biotech at J.P. Morgan, and previously held associate analyst roles at Goldman Sachs (Large Cap Biopharma) and Jefferies LLC (Global Large Cap Pharma). These roles gave him extensive experience in research across the global healthcare sector.

Mr. Scott holds a BS in molecular, cell, and developmental biology from the University of California, Santa Cruz. His expertise in both biomedical science and institutional equity research allows him to provide critical insights into major healthcare industry shifts, contributing to investment strategy and stock selection within pharma and biotech asset classes.